Association of reperfusion success and emboli in new territories with long term mortality after mechanical thrombectomy
- 28 April 2021
- journal article
- research article
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 14 (4) , 326-332
Abstract
Background The degree of reperfusion is the most important modifiable predictor of 3 month functional outcome and mortality in ischemic stroke patients treated with mechanical thrombectomy. Whether the beneficial effect of reperfusion also leads to a reduction in long term mortality is unknown. Methods Patients undergoing mechanical thrombectomy between January 2010 and December 2018 were included. The post-thrombectomy degree of reperfusion and emboli in new territories were core laboratory adjudicated. Reperfusion was evaluated according to the expanded Thrombolysis in Cerebral Infarction (eTICI) scale. Vital status was obtained from the Swiss population register. Adjusted hazard ratios (aHRs) using time split Cox regression models were calculated. Subgroup analyses were performed in patients with borderline indications. Results Our study included 1264 patients (median follow-up per patient 2.5 years). Patients with successful reperfusion had longer survival times, attributable to a lower hazard of death within 0–90 days and for >90 days to 2 years (aHR 0.34, 95% CI 0.26 to 0.46; aHR 0.37, 95% CI 0.22 to 0.62). This association was homogeneous across all predefined subgroups (p for interaction >0.05). Among patients with successful reperfusion, a significant difference in the hazard of death was observed between eTICI2b50 and eTICI3 (aHR 0.51, 95% CI 0.33 to 0.79). Emboli in new territories were present in 5% of patients, and were associated with increased mortality (aHR 2.3, 95% CI 1.11 to 4.86). Conclusion Successful, and ideally complete, reperfusion without emboli in new territories is associated with a reduction in long term mortality in patients treated with mechanical thrombectomy, and this was evident across several subgroups.Keywords
Funding Information
- Clinical Trials Unit Bern, University of Bern (84801869)
- Swiss Academy of Medical Sciences (YTCR 03/19)
This publication has 29 references indexed in Scilit:
- Long-term outcomes of acute ischemic stroke patients treated with endovascular thrombectomy: A real-world experienceJournal of the Neurological Sciences, 2018
- First Pass EffectStroke, 2018
- Importance of Reperfusion Status after Intra-Arterial Thrombectomy for Prediction of Outcome in Anterior Circulation Large Vessel StrokeInterventional Neurology, 2018
- Safety and efficacy of thrombectomy in acute ischaemic stroke (REVASCAT): 1-year follow-up of a randomised open-label trialThe Lancet Neurology, 2017
- Two-Year Outcome after Endovascular Treatment for Acute Ischemic StrokeNew England Journal of Medicine, 2017
- Infarct in a New Territory After Treatment Administration in the ESCAPE Randomized Controlled Trial (Endovascular Treatment for Small Core and Anterior Circulation Proximal Occlusion With Emphasis on Minimizing CT to Recanalization Times)Stroke, 2016
- Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trialThe Lancet Neurology, 2016
- Endovascular Stroke Management: Key Elements of SuccessCerebrovascular Diseases, 2016
- Proposed methodology and classification of Infarct in New Territory (INT) after endovascular stroke treatmentJournal of NeuroInterventional Surgery, 2015
- Twelve-Month Clinical and Quality-of-Life Outcomes in the Interventional Management of Stroke III TrialStroke, 2015